ATHA - Athira Pharma Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-12    (Delayed quote data   2025-10-28)
Last
 4.17		 Change
 ⇑ +0.05   (+1.21%)		 Volume
  21,150
Open
 4.17		 High
 4.21		 Low
 4.05
8EMA (Daily)
 3.99		 40EMA (Daily)
 3.07		 50EMA (Daily)
 2.79		 STO (Daily)
 58.609		 MACD Hist (Daily)
 -0.039
8EMA (Weekly)
 3.337		 40EMA (Weekly)
 1.54		 50EMA (Weekly)
 1.47		 STO (Weekly)
 85.312		 MACD Hist (Weekly)
 0.274
Company Profile
Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com